Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Press Statements

      Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

      Clinical Trials
      Aptar Pharma, a global leader in drug delivery and active material science solutions and services, announced its acquisition of the clinical trial materials manufacturing...

      Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

      Press Statements
      Uniting Industry Leaders to Improve Global Access to Life-Changing Therapeutics San Francisco, CA | October 7-9 – Following the resounding success of its Boston and...

      Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

      Drug Development
      Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced on June 5 2025,  that LUMRYZTM has been granted Orphan...

      ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

      Middle East and South Asia
      DECHEMA, which organises the ACHEMA, the leading trade show for the global process industry, launches ACHEMA Middle East in Saudi Arabia together with Messe...

      APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

      Press Statements
      American Plant Maintenance (APM Steam), a leading provider of steam systems maintenance services, highlights its innovative HVAC insulation services, designed to provide significant energy...

      Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

      Americas
      Thermo Fisher Scientific Inc has entered into a definitive agreement to acquire Solventum’s Purification & Filtration business for approximately US$4.1 billion in cash. The Purification...

      Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

      Drug Development
      LINDIS Biotech has received an EMA Marketing Authorization for catumaxomab, making it the only drug approved for the specific and cancer-directed treatment of...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.